Clinical Trial Update: A Clinical Study for Inactivated Vaccine Against EV71 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of an inactivated vaccine against Enterovirus 71 developed by Medigen Vaccine Biologics Corp. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Enterovirus 71 Infection

Drugs mentioned

• EV71 inactivated vaccine (Enterovirus Type 71 vaccine (inactivated))

Snippet

Sponsor: Medigen Vaccine Biologics Corp. | Conditions: Enterovirus 71 Human | Phase 2 | Status: COMPLETED